Finasteride is one of the most effective anti-androgen medicines in hair loss — and the tablet form comes with baggage that makes many women (and many prescribers) hesitate. Topical finasteride exists to keep the benefit while shrinking the baggage: the same molecule, applied to the scalp it’s meant to work on, with far less reaching the rest of you.
This page explains how the topical route works, what the evidence honestly shows, who it suits, and how prescribing works at our clinic — including the safety rules that matter for women, which are non-negotiable and covered plainly below.
- – Same DHT-blocking molecule as the tablet, applied where it’s needed — with meaningfully lower systemic exposure
- – Often compounded together with minoxidil in a single daily scalp solution
- – Unlicensed in the UK, so it’s prescribed privately by a doctor after proper assessment
- – Strict rule: not for use in pregnancy or while trying to conceive — we assess suitability carefully
What topical finasteride is — and why the route matters
Finasteride blocks 5-alpha-reductase, the enzyme that converts testosterone into DHT — the hormone that miniaturises genetically susceptible follicles in pattern hair loss. Taken as a tablet, it lowers DHT throughout the body. Applied as a scalp solution or spray, it concentrates that effect where the follicles are, while studies of the topical route consistently show much lower levels of the drug in the bloodstream compared with tablets.
For women that distinction does real work. Female prescribing of finasteride is already a specialist decision — it’s reserved mainly for post-menopausal women or those with reliable contraception, because the medicine can harm a male fetus. The topical route doesn’t remove those rules (they apply in full), but it does reduce systemic exposure, which is exactly what many women who’ve weighed the tablet are looking for.
Does it work? What the evidence honestly shows
The research base is younger than the tablet’s, and it’s honest to say so. What it shows so far: topical finasteride measurably lowers scalp DHT, improves hair counts in pattern hair loss, and in comparative work performs in the same territory as the oral form for scalp outcomes — with plasma drug levels a fraction of the tablet’s. Most published work is in men; women’s data lean on smaller studies and clinical experience, often using compounded combinations with minoxidil.
Our view, prescribed dozens of times over: it’s a genuine option, not a gimmick — strongest as part of a combination approach, and most sensible where the oral route is unwanted or unsuitable. It is not a rescue for follicles already lost, and nothing about the topical route changes hair biology’s timetable: months, not weeks.
Who it suits — and who it doesn’t
It tends to earn its place for women with confirmed female pattern hair loss who want an anti-androgen working at the follicle: those already on topical minoxidil wanting to address the hormonal driver too; those who considered tablets but prefer minimal systemic exposure; and post-menopausal women, where the prescribing picture is simplest. It’s not for anyone pregnant, breastfeeding or trying to conceive — full stop — and women with childbearing potential need reliable contraception and a proper risk conversation before any finasteride prescription, topical included. Handling matters too: the applied solution shouldn’t come into contact with a pregnant woman’s skin.
Book a Consultation
If you're experiencing female pattern hair loss, a proper diagnosis is the first step toward the right treatment.
Our consultation includes a full clinical assessment, dermoscopy, and a personalised treatment plan — all in a single appointment.
Book your consultation today — £300Including assessment, and treatment plan. See full pricing
Topical finasteride against the alternatives
| Option | How it works | Systemic exposure | Best suited to |
|---|---|---|---|
| Topical finasteride | Blocks DHT production at the scalp | Low — a fraction of the tablet’s | Follicle-level anti-androgen effect without oral dosing |
| Oral finasteride/dutasteride | Blocks DHT production body-wide | Full | Post-menopausal women under specialist care |
| Spironolactone | Blocks androgen receptors (different mechanism) | Full — oral tablet | Pattern loss with androgen signs; PCOS overlap |
| Topical minoxidil | Growth stimulant — no hormonal action | Minimal | First-line for most women; combines with all of the above |
The honest summary: minoxidil stimulates, anti-androgens protect. Many women do best with one of each, and the compounded topical route can put both in a single daily application. Our treatments comparison sets the whole field side by side, and spironolactone remains the usual first anti-androgen conversation for pre-menopausal women.
How prescribing works here
Topical finasteride is unlicensed in the UK, which doesn’t mean unavailable — it means it’s prescribed privately, by a doctor, for a properly assessed patient, and made up by a compounding pharmacy. At Hair GP that starts with diagnosis: trichoscopic examination to confirm pattern loss, blood tests where the picture needs them, and a frank suitability conversation covering the pregnancy rules. If we prescribe, you’ll get a named compounded formulation — commonly finasteride with minoxidil in one solution — with usage coaching and a review schedule, with standardised photographs.
Sensible expectations
Shedding should stabilise first, over roughly three months. Visible improvement, where it comes, shows from months four to six and keeps building to twelve. Local irritation is the commonest side effect (usually settling or solved by tweaking the formulation); systemic side effects are uncommon at topical exposure levels but we monitor for them anyway, because “uncommon” isn’t “never”. If twelve months bring no objective change on photographs, we say so and change course — continuing an ineffective prescription helps nobody but the pharmacy.
Using it well: the practical details
Topical finasteride rewards boring consistency. The routine: once daily onto a dry scalp — parting the hair to reach skin, not coating the hair itself — then hands washed, and no washing the scalp for several hours so the solution does its work. Missed a day? Carry on as normal; it’s the weekly average that treats you, and doubling up buys irritation, not catch-up. Store it out of reach of children and away from anyone pregnant, and if you share a bathroom, treat the bottle with the same respect you’d give any prescription hormone-active medicine. Formulation matters more than brand: most solutions are alcohol-based, and if your scalp objects — dryness, tightness, itch — the usual fix is switching vehicle or adjusting frequency with us, not abandoning an effective treatment over a solvable side effect.
If you’re switching from something else
Three switches come up constantly. From oral finasteride: the transition is undramatic — no washout needed, and the usual motive (wanting less systemic exposure) is served from the first application; we keep the same review schedule so photographs judge the change. From minoxidil alone: don’t swap — add. Minoxidil stimulates growth but does nothing about the androgen driver, which is why a compounded combination is often the single most sensible upgrade for a woman whose minoxidil results have plateaued. From or alongside spironolactone: the two can coexist under review — they act at different points of the same pathway — but doubling anti-androgens is a prescribing decision with monitoring attached, not a self-experiment.
What Patients Say
Not sure where to start? Ask the clinic first.
Dr Amy Vowler · GMC-registered GP · GMC 7451097
Message us on WhatsApp or give us a ring. We can't give clinical advice over a message, but we can tell you how the consultation works, what it costs and whether Dr Amy is the right person for you. No obligation, nothing to prepare.
The same timetable as every effective hair treatment: shedding stabilises over about three months, early regrowth shows from months four to six, and a fair verdict takes twelve. We review with standardised photographs so the answer is objective rather than a mirror impression.
Yes — that’s the commonest way we prescribe it. A compounding pharmacy can put finasteride and minoxidil in a single daily scalp solution, which treats the hormonal driver and stimulates growth in one application. Many women find one bottle far easier to stay consistent with than two.
Finasteride in any form must not be used in pregnancy or while trying to conceive — it can harm a male fetus. For women with childbearing potential we prescribe only alongside reliable contraception and a clear risk conversation, and pregnant women shouldn’t handle the solution. This rule has no exceptions.
Comparative research — mostly in men — shows scalp outcomes in the same territory as oral finasteride, with far lower drug levels in the bloodstream. Women’s evidence is smaller and still maturing, which is why we frame it honestly as a genuine option within a monitored plan rather than a guaranteed equivalent.
Local irritation — dryness, itch, occasional redness — is the commonest and usually settles or resolves with a formulation tweak. Because a small amount is absorbed, systemic effects are possible but uncommon at topical exposure levels; we monitor for them at reviews rather than assuming they can’t happen.
No manufacturer has taken topical finasteride through the full UK licensing process, so it’s prescribed off-licence by doctors and made by regulated compounding pharmacies — a normal, legal route used widely in dermatology. What it does mean: it should come from a doctor who has examined you, not from an online checkout.
Understand what's causing your hair loss
A 50-minute consultation with Dr Amy includes scalp microscopy, and a personalised treatment plan—giving you definitive answers rather than continued guessing.
Book Your Hair Loss Assessment£300 consultation | Parsons Green, London
Next-day appointments often available
